NYSE · WHOLESALE-CHEMICALS & ALLIED PRODUCTS · LARGE CAP
Ashland Inc. ASH
12 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY7 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$1.8B
▼ 13.7% vs FY2024
Dividend streak
7 yrs
Raised every year since 2019
EPS · FY25
$-18.23
Dividend / sh · FY25
$1.64
Payout · FY25
-9%
ROE · FY25
-35.4%
Net margin · FY25
-46.3%
Dividend coverage
-11.1×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.8B
Revenue, FY2025 · full 12-year series below
Revenue
Net income
The company lost 46 cents on every revenue dollar this year.
Per share
USD -18.23
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-35.4%
Return on equity, FY2025
ROE
Operating margin-42.5%
Net margin-46.3%
Return on assets-16.5%
Each USD of equity lost 35 cents this year.
Returned to shareholders
USD 176.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 76.0M
Net buybacksUSD 100.0M
Share of profit-20.8%
Consecutive raises7 years
USD 76.0M in dividends and USD 100.0M in buybacks went back to shareholders in a year without profit.
Growth
−2.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−8.6%
−2.0%
−6.1%
Dividend / share
+8.9%
+8.3%
+1.2%
Returned to shareholders
−13.3%
+21.7%
−9.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years−9.0%
Change, 10 years—
The share count shrank 9% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 4.6B
total assets, end of FY2025
Total assetsUSD 4.6B
EquityUSD 1.9B
CashUSD 215.0M
Gross debtUSD 1.4B
Net debtUSD 1.2B
Current ratio2.85×
Net debt stands at 61% of equity.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue $B
1.8
2.1
2.2
2.4
2.1
2.0
2.1
2.6
2.3
3.0
3.4
6.1
Operating income $B
−0.8
−0.0
0.2
0.3
0.2
−0.5
0.1
0.1
0.0
−0.1
0.1
0.0
EBITDA $B
−0.5
0.2
0.4
0.6
0.4
−0.2
0.4
0.4
0.3
0.3
0.4
0.4
Income tax $B
0.0
−0.2
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.1
−0.2
Net income $B
−0.8
0.2
0.2
0.9
0.2
−0.5
0.5
0.1
0.0
−0.0
0.3
0.2
EPS, diluted $
−18.23
3.36
3.31
16.41
3.59
−8.39
8.15
1.79
0.01
−0.47
4.54
3.00
Dividend / sh $
1.64
1.58
1.44
1.27
1.15
1.10
1.05
0.95
1.23
1.56
1.46
1.36
Payout %
−9
46
43
8
32
−13
13
53
7700
−334
32
44
ROE %
−35.4
5.7
5.6
31.0
7.6
−15.4
14.5
3.3
0.0
−0.9
10.2
·
Shares out B
·
·
·
·
·
0.06
0.06
0.06
0.06
0.06
0.07
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
46 of 46
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed